UnitedHealthcare Cancer Supportive Care - Erythropoiesis Stimulating Agents prior authorization requirements (2026)
What UnitedHealthcare generally requires to approve Cancer Supportive Care - Erythropoiesis Stimulating Agents (CPT J1449, Q5148, J0885), for Commercial plans. Yes. UnitedHealthcare generally requires prior authorization for Cancer Supportive Care - Erythropoiesis Stimulating Agents (CPT J1449, Q5148, J0885).
Medical-necessity criteria UnitedHealthcare generally applies
Patient has cancer diagnosis requiring erythropoiesis stimulating agents administered in outpatient setting
Commonly required documentation
- Clinical documentation including cancer diagnosis, hemoglobin levels, treatment plan
How to submit
- Method: portal
- Portal: UnitedHealthcare
- Typical turnaround: about 3 days
Sources & verification
Prior authorization required for erythropoiesis stimulating agents in outpatient setting. Call 888-397-8129 for assistance. Last verified 2026-05-06.
Frequently asked questions
Does UnitedHealthcare require prior authorization for Cancer Supportive Care - Erythropoiesis Stimulating Agents?
Yes. UnitedHealthcare generally requires prior authorization for Cancer Supportive Care - Erythropoiesis Stimulating Agents (CPT J1449, Q5148, J0885).
What does UnitedHealthcare require to approve Cancer Supportive Care - Erythropoiesis Stimulating Agents?
Patient has cancer diagnosis requiring erythropoiesis stimulating agents administered in outpatient setting Always confirm against the current UnitedHealthcare policy.
How long does a UnitedHealthcare prior authorization take?
UnitedHealthcare typically decides Cancer Supportive Care - Erythropoiesis Stimulating Agents requests in about 3 days. Timeframes vary; check the payer portal.
Submitting Cancer Supportive Care - Erythropoiesis Stimulating Agents to UnitedHealthcare?
Praxigen checks your clinical note against these criteria before you submit and drafts a policy-cited appeal if it is denied. You review and submit; nothing is sent automatically.